Revolve Wealth Partners, LLC

Position in ABT — Abbott Laboratories

CIK 1808992 Hackensack, NJ

Position in ABT

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$774,828

+$384,477 QoQ

Shares Held

8,539

+124.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#1,615

of 2,959 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Revolve Wealth Partners, LLC holds $2,185,633 across 6 Medical Devices names. ABT ranks #1 (35.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	8,539	$774,828
2	DXCM	Dexcom Inc	6,253	$421,139
3	SYK	Stryker Corp	1,015	$319,562
4	PODD	Insulet Corp	1,586	$241,468
5	HAE	Haemonetics Corp	2,970	$222,750
6	EW	Edwards Lifesciences Corp	2,276	$205,886

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$774,828	8,539	+124.6%	Shares	Sole	2026-07-09
2026-03-31	$390,351	3,802	-17.5%	Shares	Sole	2026-04-13
2025-12-31	$577,336	4,608	-3.3%	Shares	Sole	2026-01-20
2025-09-30	$638,224	4,765	+73.7%	Shares	Sole	2025-10-14
2025-06-30	$373,211	2,744	+10.3%	Shares	Sole	2025-07-28
2025-03-31	$330,033	2,488	+19.2%	Shares	Sole	2025-04-14
2024-12-31	$236,173	2,088	-34.2%	Shares	Sole	2025-03-19
2024-09-30	$361,639	3,172	+62.2%	Shares	Sole	2024-10-18
2024-03-31	$222,318	1,956	+6.3%	Shares	Sole	2024-04-15
2023-12-31	$202,528	1,840	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.